KMDA Kamada Pharma: Nilai Bisnis

Kamada Ltd. (KMDA) is leveraging growing global demand for plasma-derived therapies, expanding its reach through new licenses in the US. Simultaneously, the business is implementing eco-friendly chemical waste recycling and wastewater treatment in accordance with ESG standards. The current enterprise value stands at 406.07, and the price trend shown below on GURU.Markets confirms a stable cash flow from the sale of vital orphan drugs.

To minimize risks when valuing Kamada Ltd. (KMDA), it is essential to consider the total acquisition costs, determined by the sum of market capitalization and net debt. An analysis of the company's enterprise value allows for an assessment of the asset's real price as Kamada Ltd. (KMDA) transitions toward organic growth and the development of plasma alliances following the conclusion of its active M&A phase.